Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Catchatourian

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Diabetic Medicine : a Journal of the British Diabetic Association|April 19, 2016
Localized insulin amyloidosis with use of concentrated insulin: a potential complicationA Mangla, G J Kim, N Agarwal, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 9, 1999
Social factors affecting interest in participating in a prostate cancer chemoprevention trialM M Lee, R M Chamberlain, R Catchatourian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
High-dose melphalan with autotransplantation for refractory multiple myeloma: results of a Southwest Oncology Group phase II trialD H Vesole, J J Crowley, R Catchatourian, et al.
International Journal of Cancer|November 25, 2000
Television and news print media are effective in recruiting potential participants in a prostate cancer chemoprevention trialT D Chung, I I Park, L Ignacio, et al.
Blood Cancer Journal|January 3, 2015
Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center studyA J Greenberg, S Philip, A Paner, et al.
Blood Cancer Journal|February 14, 2015
Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center studyA J Greenberg, S Philip, A Paner, et al.
Leukemia|August 1, 2019
A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosisJ Mascarenhas, H Kosiorek, J Prchal, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Diabetic Medicine : a Journal of the British Diabetic Association|April 19, 2016
Localized insulin amyloidosis with use of concentrated insulin: a potential complicationA Mangla, G J Kim, N Agarwal, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 9, 1999
Social factors affecting interest in participating in a prostate cancer chemoprevention trialM M Lee, R M Chamberlain, R Catchatourian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
High-dose melphalan with autotransplantation for refractory multiple myeloma: results of a Southwest Oncology Group phase II trialD H Vesole, J J Crowley, R Catchatourian, et al.
International Journal of Cancer|November 25, 2000
Television and news print media are effective in recruiting potential participants in a prostate cancer chemoprevention trialT D Chung, I I Park, L Ignacio, et al.
Blood Cancer Journal|January 3, 2015
Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center studyA J Greenberg, S Philip, A Paner, et al.
Blood Cancer Journal|February 14, 2015
Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center studyA J Greenberg, S Philip, A Paner, et al.
Leukemia|August 1, 2019
A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosisJ Mascarenhas, H Kosiorek, J Prchal, et al.
Pageof 2